Metropolis Healthcare shows positive financial performance in Q2 2024-2025, advised to hold stock.

Metropolis Healthcare, a midcap company in the hospital and healthcare services industry, has recently declared its financial results for the quarter ending September 2024. The stock call for the company by MarketsMOJO is 'Hold'.

According to the financials, Metropolis Healthcare has shown positive performance in the second quarter of the fiscal year 2024-2025. The company's score has improved from 8 to 19 in the last three months.

One of the key factors contributing to this positive performance is the company's ability to manage interest payments, with the Operating Profit to Interest ratio being the highest in the last five quarters at 18.76 times. Additionally, the company has been reducing its borrowing as compared to equity capital, with the Debt-Equity Ratio being the lowest at 0.16 times and falling each half year in the last five periods.

Metropolis Healthcare has also generated higher cash revenues from business operations, with the Operating Cash Flow being the highest at Rs 264.07 crore in the last three years. The company's net sales have also shown a positive trend, with the highest being Rs 349.79 crore in the last five quarters.

The company's efficiency has also improved, with the Operating Profit Margin being the highest at 25.70% in the last five quarters. The Profit Before Tax less Other Income has also shown a positive trend, with the highest being Rs 58.27 crore in the last five quarters and a growth of 30.9% over the average of the previous four quarters.

The Profit After Tax has also shown a positive trend, with the highest being Rs 46.52 crore in the last five quarters and a growth of 35.9% over the average of the previous four quarters. This has resulted in a higher Earnings per Share of Rs 9.08, indicating increasing profitability and higher earnings for shareholders.

However, there are some areas that need improvement, such as the company's short-term liquidity, with the Cash and Cash Equivalents being the lowest at Rs 54.36 crore in the last six half yearly periods. Additionally, the company's non-operating income has shown a significant increase, which may not be sustainable in the long run.

Overall, Metropolis Healthcare has shown positive financial performance in the second quarter of the fiscal year 2024-2025, with improvements in key areas such as interest management, debt reduction, and cash flow generation. Investors are advised to hold their stock in the company, as recommended by MarketsMOJO.